NeXstar regulatory update

NXTR's DaunoXome received U.K. marketing approval to treat advanced Kaposi's sarcoma associated with HIV. DaunoXome is a liposomal formulation of daunorubicin. NXTR (Boulder, Colo.) plans to begin sa...